AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Sciatica Epidemiology Forecast Report 2019-2028: Total Diagnosed Prevalent Cases of Sciatica in the Seven Major Markets were 26,761,073 - ResearchAndMarkets.com

November 28, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 28, 2019--

The “Sciatica - Epidemiology Forecast To 2028” report has been added to ResearchAndMarkets.com’s offering.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this research, the total diagnosed prevalent cases of Sciatica in the seven major markets were 26,761,073. Moreover, the total diagnosed prevalent cases of Sciatica in the US were 12,388,685 cases in 2017, out of which the total cases lumbar disc herniation in the US was 11,149,817 cases in 2017.

Report Scope

  • The report covers the detailed overview of Sciatica explaining its causes, symptoms, and classification, pathophysiology, diagnosis and treatment patterns.
  • The report provides insight about the historical and forecasted patient pool for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Sciatica.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology by type-specific cases and severity specific cases of Sciatica in the 7MM.

Key Strengths

  • 10-Year Forecast of Sciatica epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of Sciatica
  • Prevalent Cases according to segmentation

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Key Topics Covered:

1. Key Insights

2. Disease Background and Overview: Sciatica

2.1. Introduction

2.2. Difference between Sciatica and Lower Back Pain

2.3. Symptoms of Sciatica

2.4. Causes of Sciatica

2.4.1 Spinal Disc Herniation

2.4.2 Spinal Stenosis

2.4.3 Pregnancy

2.4.4 Piriformis syndrome

2.4.5 Osteoarthritis

2.4.6 Spondylosis and spondylolisthesis

2.4.7 Nondiscogenic causes

2.5. Pathophysiology of disk-related sciatica

2.5.1 Clinical observation

2.5.2 Physiologic Variants of Sciatica

2.6. Pathophysiological Mechanisms in Radicular Pain

2.6.1 Inflammatory mechanism

2.6.2 Immunological mechanism

2.6.3 Compressive mechanism

2.6.4 Lumbar spinal stenosis

2.6.5 Skeletal Causes of Radiculopathy

2.6.6 Lumbar bulging or herniated disc

2.7. Biomarkers for Sciatica

2.8. Diagnosis of sciatica

2.8.1 Indicators for sciatica

2.8.2 Imaging

2.8.3 Selective Nerve Root Block (SRNB)

2.9. Differential Diagnosis

2.10. Clinical Guidelines for the Diagnosis for Sciatica

2.10.1 Clinical guideline for diagnosis for General Practice

2.11. Diagnostic algorithm

3. Epidemiology and Patient Population: Key Findings

3.1 7MM Total Diagnosed Prevalent Patient Population of Sciatica

4. Country Wise-Epidemiology of Sciatica

4.1 United States

4.1.1 Assumptions and Rationale

4.1.2 Assumptions and Rationale

4.1.3 Sciatica Diagnosed Prevalence in the United States

4.1.4 Lumbar Disc Herniation Cases in the United States

4.1.5 Sciatica Gender-specific Diagnosed Prevalence in the United States

4.2 EU5 Countries

4.2.1 Assumptions and Rationale

4.3 Germany

4.3.1 Sciatica Diagnosed Prevalence in Germany

4.3.2 Lumbar Disc Herniation Cases in Germany

4.3.3 Sciatica Gender-specific Diagnosed Prevalence in Germany

4.3.4 Sciatica Age-specific Diagnosed Prevalence in Germany

4.4 France

4.5 Italy

4.6 Spain

4.7 United Kingdom

4.8 Japan

5 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/5ftfmc

View source version on businesswire.com:https://www.businesswire.com/news/home/20191128005319/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/28/2019 05:56 AM/DISC: 11/28/2019 05:56 AM

http://www.businesswire.com/news/home/20191128005319/en